Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|June 25, 2014
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-TE J Small, C S Higano, P W Kantoff, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 1999
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trialL C Borish, H S Nelson, M J Lanz, et al.Nursing for Women'S Health|February 13, 2025
Did Universal Alcohol Screening and Brief Interventions Delivered in the Context of Reproductive Health Care Universally Reach Demographically Diverse Patients?Megan Waddell, Janice Vendetti, Corrie B Whitmore, et al.The Journal of Allergy and Clinical Immunology|June 9, 2001
Efficacy of soluble IL-4 receptor for the treatment of adults with asthmaL C Borish, H S Nelson, J Corren, et al.AIDS (London, England)|April 19, 2000
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study GroupJ B Angel, K High, F Rhame, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research GroupN J Meropol, D E Wood, J Nemunaitis, et al.The Journal of Urology|July 27, 2011
Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancerSimon J Hall, Laurence Klotz, Allan J Pantuck, et al.The Journal of Rheumatology|July 2, 2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanerceptPhillip J Mease, Christopher T Ritchlin, Richard W Martin, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.International Immunopharmacology|November 17, 2001
Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylationS M Vogen, N J Paczkowski, L Kirnarsky, et al.Pageof 5